ROVI

Rovi acquires BMS facility as part of $250M manufacturing deal

Laboratorios Farmacéuticos Rovi, which goes by Rovi, inked a $250 million deal with Bristol Myers Squibb that gives the Spanish CDMO an Arizona plant.

Joseph Keenan Sep 30, 2025 9:08am

financials earnings profit profit miss earnings miss decline revenue decline

Rovi warns analyst profit consensus is 10% to 15% too high

Feb 13, 2025 9:58am

Granules receives Form 483 over poor document controls and more

Sep 19, 2024 10:11am

Rovi receives offers for potential sale of €2B-plus CDMO group

Jun 27, 2024 2:21pm

Rovi wins FDA nod to make Moderna's COVID shot at Spanish plant

Feb 28, 2024 11:22am